Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs-Reference-Cited by-同舟云学术

Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs

Published:2016-11-22 Issue:sup2 Volume:15 Page:9-15
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Sessa Maurizio¹,Rafaniello Concetta¹,Sportiello Liberata¹,Mascolo Annamaria¹,Scavone Cristina¹,Maccariello Alessandra¹,Iannaccone Teresa²,Fabrazzo Michele²,Berrino Liberato¹,Rossi Francesco¹,Capuano Annalisa¹

Affiliation:

1. Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Second University of Naples, Naples, Italy

2. Department of Psychiatry, Second University of Naples, Naples, Italy

Funder

Second University of Naples

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2016.1221397

Reference21 articles.

1. European Medicine Agency. Good practice guide on recording, coding, reporting and assessment of medication errors. [cited 2016 May 05]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/11/WC500196979.pdf.

2. European Medicine Agency. G Good practice guide on risk minimisation and prevention of medication errors. [cited 2016 May 05]. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/11/WC500196981.pdf.

3. Legislative Decree No. 219 of April 24, 2006 on the Implementation of Directive 2001/83/EC (& Subsequent Amending Directives) on the Community Code on Medicinal Products for Human Use, and the Directive 2003/94/EC. Rome (Italy): Italian government; Gazzetta Ufficiale n. 142; 2006 Jun 21.

4. Assessment of a New Instrument for Detecting Preventable Adverse Drug Reactions

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing;Drug Safety;2023-12-07

2. Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines;Frontiers in Cardiovascular Medicine;2023-11-24

3. Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database;Drugs - Real World Outcomes;2023-10-31

4. Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL;Frontiers in Pharmacology;2023-08-16

5. Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis;Journal of Clinical Medicine;2023-06-23